Infection risk prevention following total knee arthroplasty  by Levent, T. et al.
Orthopaedics & Traumatology: Surgery & Research (2010) 96, 49—56
ORIGINAL ARTICLE
Infection risk prevention following total knee
arthroplasty
T. Leventa,∗, D. Vandeveldeb, J.-M. Delobelleb, P. Labourdetteb,
J. Létendardb, P. Lesageb, P. Lecocqc, M. Dufoura
a Infection Control Team, polyclinique du Parc, 48, rue H.-Barbusse, 59880 Saint-Saulve, France
b Orthopedic Surgery Department, polyclinique du Parc, 48, rue H.-Barbusse, 59880 Saint-Saulve, France
c Internal Medicine Department, Denain Hospital, 25 bis, rue J.-Jaurès, 59230 Denain, France
Accepted: 19 October 2009
KEYWORDS
Guidelines;
Infection control;
Quality program;
Total knee
replacement;
Practice
Summary
Introduction: Implant infection is serious; prevention is mandatory, and requires assessment.
The present study assessed the incidence of deep surgical-site infection (SSI) at 1 year follow-
ing total knee arthroplasty (TKA) and adherence to skin preparation, antibiotic prophylaxis,
screening and prevention in case of methicillin-resistant S. aureus (MRSA).
Hypothesis: Adherence to prevention measures reduces infection risk secondary to TKA.
Material and methods: A prospective study of the incidence of SSI following primary TKA was
run from December 1st 2005 to December 31st 2006 in a continuous series of 364 operations in
359 patients, excluding cases of septic or aseptic revision. Each implant was followed up for
12months. Adherence to practice was assessed by independent observers. Antibiotic prophy-
laxis was assessed; skin preparation was scored (out of 10); MRSA was systematically screened
for, and preventive measures were assessed in positive cases. Median follow-up was 12 months.
Patients with less than 11months’ FU were contacted by telephone. Median age was 72 years
(range, 45—92 years). Eighty-seven percent of patients had ASA scores of 2; 14% were diabetic,
and 42% obese. Mean surgery time was 70min (range, 30—164min). Among the implants, 81.5%
were cemented. Eighty-six percent of operations had NNIS scores of 0. Infection risk linked to
theater environment and teams was under control.
Results: Fourteen patients were lost to follow-up and excluded from analysis. The incidence
of infection was 1.4% (n = 5/350) (95%CI [0.41—3.22]). Three of the infections were early
(≤ 1month), and two were polymicrobial. Antibiotic prophylaxis was implemented correctly
in 99% of cases, with skin preparation scores of 8.75 in 61% of cases and of 10 in 39%. Among
the pattients, 2.5% were MRSA-positive, none of whom developed infection. Infection preven-
tion measures were applied in only half of the MRSA-positive cases. No MRSA-positive patients
developed SSI.
DOI of original article:10.1016/j.rcot.2009.11.005.
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Discussion: SSI incidence in the present series was low, but certainly underestimated. Assess-
ment found good implementation of infection prevention protocols, with SSI occurring randomly
with regard to adherence parameters (antibiotic prophylaxis, skin preparation, MRSA status).
Conclusion: Our hypothesis could not be conﬁrmed. The study was mandatory for a health-care
institution, and indispensable from a legal standpoint.
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mplant infection is especially serious in terms of morbidity
nd cost [1]. Infection risk prevention is codiﬁed and subject
o good practice recommendations [2]. Assessment should
e routine [3], as part of general practice quality control.
The present study measured the incidence of deep
urgical-site infection (SSI) secondary to total knee replace-
ent (TKA), and assessed adherence to infection risk pre-
ention measures: skin preparation, antibiotic prophylaxis,
nd screening and management for methicillin-resistant
taphylococcus aureus (MRSA), for which corrective action
as advised as appropriate.
The hypothesis was that adherence to infection risk
revention measures would reduce the incidence of SSI fol-
owing TKA.
aterial and methods
eep surgical site infection incidence study
prospective study of the incidence of SSI following TKA
as run from December 1st 2005 to December 31st 2006 in a
ontinuous series of 364 operations performed in the Poly-
linique du Parc, Saint Saulve (France). Following inclusion
ver this 13-month period, a 12-month follow-up was con-
ucted in all cases.
The inclusion criterion was primary TKA, with or without
rior history of surgery. Cases of aseptic (loosening, wear)
nd septic revision were excluded. SSI was deﬁned following
oran et al. [4] as applied in France [5,6] (Table 1). Bac-
Table 1 Deep infection after knee arthroplasty. Clinical and bact
[5] Infection occurring within 30 days following surgery or with
material, involving tissue, organs or spaces at or below the
surgery, and diagnosed by:
Case 1: purulent effusion from a drain below the aponeuro
Case 2: spontaneous dehiscence of incision or opening by t
> 38 ◦C, localized pain or sensitivity on palpation
And micro-organism isolated by culture, obtained aseptica
culture (excluding negative culture without antibiotherapy
Case 3: abscess or other sign of infection on revision surge
[8] > 3 peroperative samples (no antibiotics for 2weeks)
≥ 3 samples positive for the same bacillus
≤ 2 samples positive for the same bacillus:
—Virulent bacillus (S. aureus, P. aeruginosa, etc.)
—Discussion between surgeon and infectologist according
Propionibacterium. . .)
A
(
d
s
sspective prognostic study.
rights reserved.
eriological data were derived from peroperative samples
aken under strict asepsis (direct puncture, peroperative tis-
ue and/or material samples) [7,8]. Superﬁcial swabs (ﬁstula
pening) were excluded, thereby excluding superﬁcial infec-
ions from the ﬁnal analysis. SSI was diagnosed by consensus
fter discussion between surgeon, infectologist and study
oordinator.
urgical protocol
perations were performed in 4 surgery rooms equipped
ith laminar ﬂow. Terminal ﬁltration was by High Efﬁ-
iency Particulate Air (HEPA) ﬁlter, ﬁltering out 99.9% of
0.3( particles. Annual air particle control conﬁrmed that
he surgical rooms met quality requirements (ISO5 NFX 44-
01 air cleanliness norm) [9].
The surgical team wore sterile robes, masks and double
loves. Hand disinfection was by rubbing with a hydro-
lcoholic solution. Theater maintenance comprised ﬂoor
io-cleansing and ﬂat-surface spraying with detergent-
isinfectant at the start of the surgical program and between
perations. Furnishings were damp-dusted at the end of the
rogram.
ood practice assessment
dherence was assessed against local recommendationseriological deﬁnitions.
in 1 year in case of implant, prosthesis or prosthetic
covering aponeurosis or still open or manipulated during
sis or in the organ, site or space
he surgeon with at least one of the following signs: fever
lly by organ harvesting or site or space sampling OR without
)
ry, histopathology, imaging or interventional radiology
to clinical aspect in case of skin ﬂora (CNS,
Table 2).
Antibiotic prophylaxis: injection molecule, duration,
ose and time were recorded by the anesthetist [10]. The
tudy team performed a ﬁnal assessment according to the
tudy criteria [11].
Infection risk prevention following total knee arthroplasty 51
Table 2 Local recommendations.
Surgical antibiotic
prophylaxis [11]
Joint implant
Cefazolin 2 g preoperative, then 1 g/8 h 24—48 h
In case of beta-lactamin allergy or proven MRSA colonization: vancomycin 15mg/kg preoperative,
then 10mg/kg par 8 h 24—48 h
IV antibiotic at induction of anesthesia or within the hour preceding surgery
Skin preparation [2] In the ward:
Eve of surgery: shower (hibiscrub®)
Day of surgery: depilation (shaving), wash (hibiscrub®), liaison report
Theater: cleaning (hibiscrub®), sterile water rinse, sterile band drying, antiseptic (hibitane
drape®), sterile compresses, 2-coat application, drying before drape application, liaison report
at end of surgery
MRSA screening Investigation of MRSA risk factors (recent history of surgery, chronic skin lesion)
Systematis preoperative screening by swab (nose and any skin lesion(s) during the month
preceding surgery)
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MRSA: Methicillin-resistant Staphylococcus aureus.
Skin preparation: the study team assessed implementa-
tion of a protocol based on French national recommenda-
tions [2], using the ward and theater liaison reports. Skin
preparation was scored out of 10 [12]: ﬁve points for skin
preparation in the ward (2.5 for shower, 2.5 for depilation)
and ﬁve points for skin preparation in the surgery room (1.25
for cleaning, 2.5 for antisepsis and contact time, and 1.25
for the antiseptic employed).
Pre-operative MRSA screening: the patient’s surgeon
systematically prescribed a nasal swab, performed by a
biologist of the patient’s choosing, plus another for any cuta-
neous lesions (chronic or not). MRSA was detected by culture
(MRSATM, Biomérieux, France). Results were recorded in the
patient’s treatment or consultation ﬁle. In case of positive
ﬁndings, the study team assessed preventive action (treat-
ment ﬁle, prescription form, anesthesiology ﬁle).
Stomatologic examination was not systematic.
Cohort characteristics
Five surgeons performed 364 TKAs in 359 patients (73%
female) during the inclusion period. Median patient age
was 72 years (range, 45—92 years) (Table 3). Forty-two per-
cent of patients (n = 154/364) were obese (body-mass index
[BMI] ≥ 30). Eighty-seven percent (n = 312/364) had Ameri-
can Society of Anesthesiologists (ASA) scores of 2 or 3 (mild
or severe systemic disease, respectively).
Eight patients (2%) presented with pre-operative
systemic infection (seven urinary infections and one
streptococcal erysipelas). Respectively 4.5% (16/364),
3.6% (13/364) and 1% (4/364) presented with respira-
tory insufﬁciency, smoking habit or immunodepression
(immunosuppressors, long-course corticotherapy, recent
high-dose corticotherapy, neutropenia less than 500 per
millimetre cube, chemoradiotherapy). Fourteen percent
(50/364) were diabetic. Among them, 22.2% (81/364)
had a history of knee surgery (meniscectomy, osteotomy,
arthroscopy). The postoperative blood-transfusion rate was
12% (44/364). TKA was indicated for primary arthritis
o
e
c
p
fcontamination (mupirocin 3 days), adaptation of surgical
stead of cefazolin) [11]
ithout history of infection (no rheumatoid polyarthri-
is).
An anteromedial approach was used in 76% (276/364)
f cases. Associated surgery (5%) concerned the patel-
ar retinaculum or anterior tibial tuberosity transposition.
KAs were cemented in 81.5% (297/364) of cases,
nd systematically contained antibiotics (gentamicin, or
rythromycin-colistin). The National Nosocomial Infection
urveillance System (NNIS) score was 0 in 86% (311/364) of
ases. Drainage was systematically employed for between
8 and 72 hours (max.).
ata collection
methodology guide was provided to all surgeons, with
nformation to the surgery teams and ward staff. One
orm was ﬁlled in per patient and per implant, comprising
atient data (gender, age, known SSI risk factors, and ASA
core [13]), operative data (date, duration, laminar ﬂow,
pproach and associated surgery, cementing, NNIS score
14], and antibiotic prophylaxis) and postoperative data
wound complications, non related with the knee infection
hich were not located in the knee, revision without infec-
ion, or SSI). Patients were considered obese when the BMI
xceeded 30 on the international scale [15]. The form also
ontained all of the informations regarding good practice.
After discharge, patients were followed up at a rhythm
et by the surgeon. The survey form was distributed to the
urgery ofﬁce, so as to ensure continuity. The OSOFT6TM
oftware package, employed in the institution for medi-
al ﬁles in general (admission, clinics, prescription), was
sed to gather information in postoperative clinics and to
ist those patients with less than 12months’ FU, who were
hen contacted by telephone (at home and/or via their GP,
r at their residential institution: retirement home, postop-
rative care or long-stay institution). Patients who did not
ome to follow-up clinics and could not be contacted by tele-
hone within 12months post-surgery were considered lost to
ollow-up.
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Table 3 Patient, operative and postoperative data (%).
Data Non-infected n = 359 Infected n = 5
Cohort characteristics
BMI 18.5—30 209 (58.2) 1/5
31—≥ 41 150 (41.7) 4/5
ASA score 1 51 (14.2) 1/5
2 265 (73.8) 2/5
3 43 (12) 2/5
NNIS score 0 308 (85.8) 3/5
1 51 (14.2) —
2 — 2/5
Surgical data
Median surgery time 70min (range, 30—164) 65min (range, 60—73)
Approach Lateral 20 (5.6) —
Anteromedial 271 (75.5) 5/5
Mid vastus 68 (18.9) —
Associated surgery PRR 12/19 (63.2) —
ATTT 3/19 (15.8) —
PRR +ATTT 4/19 (21) —
Cemented implant 293 (81.6) 4/5
Implant brand HLSTM (Tornier) 80 (22.3) 1/5
ScoreTM (Amplitude) 226 (63) 3/5
SKSTM (Aston) 53 (14.8) 1/5
Postoperative incidents Necrosis 4 1
Inﬂammatory scar 1 —
Hematoma 2 1
Prevention criteria
Correct antibiotic prophylaxis 355 (98.9) 5/5
Skin preparation score 10 140 (39) 3/5
8.75 219 (61) 2/5
MRSA+ 9/360 (2.5) —
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PRR: patellar retinaculum release; ATTT: anterior tibial tuberosity
ologists; NNIS: National Nosocomial Infection Surveillance System
The list of patients included in the study was cross-
eferenced with the pharmacy records for antibiotic
rescriptions over the same period and with the insti-
ution’s medical information system data for implant
nfection.
Infected patients were managed by the institution’s
nfectologist, whose records conﬁrmed and speciﬁed the
SI.
urvey management
he survey was managed by the operational hygiene team.
re-, per- and postoperative information was recorded by
he theater hygiene nurse and validated by the hygiene
hysician, who cross-referenced the survey forms, the
dmission and consultation ﬁles and the information from
he other above-mentioned data-bases.tatistical analysis
he data were entered into EPI604Fr software for Bartlett
2 and Wilcoxon analysis.
p
h
s
o
o5/9 NA
sfer; BMI: body-mass index; ASA: American Society of Anesthesi-
esults
eep surgical site infection incidence and
escription
t least 12months’ follow-up was achieved in 78.5%
286/364) of patients. Telephone contact, for the 78
atients having not more than 11months’ follow-up, was
nformative (response or death) in 82% of cases (64/78). No
eaths were linked to SSI. For 14 of these 78 patients, no
nformation was available (Fig. 1), and they were excluded
rom SSI incidence analysis.
The denominator in calculating SSI incidence combined
he 286 patients with at least 12months’ FU, the 54 tele-
hone respondents and the 10 cases of death during the
tudy period: i.e., 350 patients in all.
Five SSIs were detected (Table 4), for an incidence of
.42% (5/350) (95% CI [0.41—3.22]). Four of these ﬁve
atients were obese (including one morbid obesity). One had
istory of ipsilateral limb surgery. One patient had an ASA
core of 1, 2 of 2 and 2 of 3. There were no cases of previ-
us peri- and/or intra-articular inﬁltration, corticosteroids
r hyaluronic acid injection. Median surgery time was 70min
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(range, 30—164) for patients free of SSI and 65min (range,
60—73) in case of SSI. In 97% (349/359) of SSI-free patients
and 100% (5/5) of cases of SSI, surgery time was shorter than
the 75◦ percentile.
Skin preparation score was 10/10 in three of the
ﬁve cases. SSIs were evenly distributed between sur-
geons. Three cases were of early (1stmonth) infection.
Four of the six peroperative samples were Gram-positive
and MRSA was isolated in one deep peroperative sam-
ple.
Infection risk prevention assessmentSurgical antibiotic prophylaxis was properly performed in
99% of cases. Cefazolin and vancomycin were employed in
respectively 96% and 4% of cases (Table 3). Ninety-nine per-
cent (361/364) of prescriptions were for 24 hours, two for
I
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Table 4 Details of the ﬁve infected primary total knee arthropla
Case Sex Age NNIS Surgery
time
(minute)
Skin
prep.
score
Antibio
prophy
1 F 77 0 65 10 Cefazo
24 hr
2 F 81 1 60 8.75 Cefazo
24 hr
3 M 60 1 70 8.75 Cefazo
24 hr
4 F 71 0 60 10 Cefazo
24 hr
5 F 82 1 73 10 Cefazo
24 hr
*NNIS: National Nosocomial Infections Surveillance; # Deep surgical
sensitive Staphylococcus aureus.p breakdown.
8 hours and in one case the duration was not speciﬁed in
he anesthesiology records.
Skin preparation score was 8.75 in 61% of cases and
0 in 39%. The most frequent error was failure to per-
orm a second application or to respect the time of action
f the antiseptic. Seventy-three percent of patients had
ad oral instructions regarding preoperative showering on
he eve of surgery or during the anesthesiology clinics.
hlorhexidine-based substances (chlorhexidine foam solu-
ion or chlorhexidine in alcohol for local application) were
sed in 96% of cases and povidone iodine in 4%.
Ninety-nine percent of patients underwent MRSA screen-
ng, at a median 13 days before surgery (range, 0—90 days).
n nine patients (2.5%), MRSA was found. Seven percent
29/364) presented one or more MRSA risk factors (recent
istory of surgery, cutaneous lesion, referral from high-risk
ards, and notably long-term rehabilitation units) with sig-
iﬁcantly elevated risk of infection (P < 10-4). In case of
sties.
tic
laxis
Onset # Bacteriology
lin, 6 S. anginosus
lin, 9 Sterile
lin, 1 MSSA K. pneumoniae CTX-S
lin, 1 E. faecalis Ampi-SP.mirabilis CTX-S
lin, 1 MSSA
site infection onset (months postoperative); MSSA: methicillin-
54
Table 5 Comparative data.
Date Number FUa SSIb
Peersman et al. [18] 2001 6,489 84 0.39
Lecuire et al. [19] 2003 1,016 120 1.77
Blom et al. [20] 2004 931 78 1
Eveillard et al. [17] 2005 210 25 4.29
Phillips et al. [21] 2006 4,788 180 0.86
Debarge et al. [16] 2007 923 43 2.1
Chesney et al. [22] 2008 1,509 77 1
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eaMean follow-up (months); bdeep surgical site infection inci-
dence.
ositive screening, corrective measures (nasal mupirocin
nd adapted antibiotic prophylaxis) failed to be applied in
ve cases due to ignorance of guidelines and/or negligence.
o MRSA-positive patients had SSI.
mpact of prevention measures
one of the classic risk factors (obesity, diabetes, history
f ipsilateral limb surgery, ASA score or NNIS score) could
hus be analyzed. The impact on SSI of failure to implement
revention, in the form of incomplete skin preparation, was
ot signiﬁcant: relative risk, 0.43 (95% CI [0.07 < RR < 2.55]).
No patients with SSI had been MRSA positive for MRSA
efore surgery. For half of the MRSA-positive patients, pre-
ention measures had failed to be implemented (ignorance
f guidelines and/or negligence), without SSI ensuing. Fail-
re to apply antibiotic prophylaxis recommendations was
are in the present study, and without impact.
iscussion
he present study falls under care-facility obligations with
egard to implementing surveillance and infection risk pre-
ention strategies, notably in surgery. We are required to
dentify surveillance indicators derived from a recognized
ethodology, often as part of the French ‘‘INCISO’’ SSI
urveillance program. The other aspect concerns assessment
f the implementation of good practice recommendations.
Our center, with a high volume of TKA, sought to set
p a quality assurance program meeting the described
equirements. The present assessment of working practice
llustrates this.
Mean surgery time was shorter than reported elsewhere
Table 5).
ritical analysis of deep surgical site infection
ncidence, and study limitations
SI incidence in the present series was low, and in the
ower range (0.39% to 4.29%) of previous reports that had,
owever, longer follow-up (over 7 years as a mean for
he relevant studies as a whole [16—22], compared to the
resent median of 12 months). The difﬁculties inherent
o this kind of survey, however, are to be borne in mind.
he percentage of patients with less than 12 months’ FU
s
l
a
t
iT. Levent et al.
n the present study was considerable, and this represents
n important limitation given the interval stipulated in
he deﬁnition of deep SSI [5]: 30 days postoperatively, or
ithin 1 year in case of prosthetic implantation. The per-
entage lost to follow-up was ﬁnally quite low, but the
uality of the information gleaned from telephone contact
s obviously open to discussion. The reason given for not
ttending follow-up clinics was the absence of any compli-
ation (mechanical and/or infectious). Despite this bias,
hese patients were included in calculating the denomina-
or. Non-respondents were considered lost to follow-up, and
xcluded from analysis.
It can obviously not be ruled out that infected patients
hom we failed to identify may have contacted some other
urgeon or consulted in a specialized osteoarticular infection
enter. Even so, we would agree with Lecuire et al. [19] that
nfected patients tend to remain loyal to their surgeon.
The rarity of infection accounts for the wide conﬁdence
nterval, which hinders comparison with other centers’
eports. Our present rate of incidence is, however, very
ikely an underestimation.
Apart from such technical epidemiological problems,
onﬁrming SSI is by no means straightforward in certain
ituations, despite apparently limpid deﬁnitions. This is
ndeed the main problem faced in such a survey. For
xample, case no.2 was deﬁned as SSI by consensual clin-
cal analysis despite non-acceptable bacteriological ﬁndings
superﬁcial swab sampling) and a negative peroperative
ample! ‘‘Managing an infected prosthesis means entering a
omain of diagnostic, bacteriologic and therapeutic doubt’’
23].
This raises the issue of the role of SSI surveillance as a
igniﬁcant element in the ﬁght against nosocomial infection,
nd indeed of the regulation-bound nature of SSI surveil-
ance. Historically, the strategy initiated in France in the
990s in the form of national and regional networks enabled
he scale of the issue to be appreciated, the main risk fac-
ors to be identiﬁed, the national ISO-RAISIN data-base to
e constructed and the SSI rate to be shown to decrease
hen prevention was coupled to epidemiological surveil-
ance. As Hajjar states in his editorial [24], SSI rates are
ot simple equations! They are difﬁcult to interpret, even
t local level, due to methodological difﬁculties. Compar-
ng SSI rates is made all the more difﬁcult by the number of
ariability factors (indicator sensitivity/speciﬁcity, quality
f care, work organization and staff qualiﬁcation). To quote
ajjar again, ‘‘It is not a matter of questioning the legiti-
acy of information provided to users, but of insisting on the
irtual absence of scientiﬁc certainty as to the improvement
f care quality with the publication of infection rates.’’
oreover, the technical demands of producing the indicator
study-team work-load, difﬁcult data collection, low-grade
nformation systems, unequal commitment of the various
ontributors, incomplete exhaustiveness, etc.) are oner-
us.
Finally, implementing preventive measures of proven
fﬁcacy does avoid most cases of SSI. It therefore
eems more beneﬁcial (for the patient) and certainly
ess costly (for the care facility) to focus on prevention
nd the assessment of the quality of implementa-
ion, even if this means reporting SSI rates at longer
ntervals.
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Assessment of practice
The present study was not a self-assessment, but an audit
performed by independent survey team (hygiene physician
and nurse).
Surgical antibiotic prophylaxis was assessed on several
occasions in our institution, stimulating orthopedic physi-
cians and anesthetists to implement the French Society
of Anesthesiology and Intensive Care (SFAR) recommen-
dations scrupulously [11]. The importance of respecting
national recommendations from the point of view of litiga-
tion (especially in orthopedic surgery) largely explains the
good present results.
Skin preparation followed a written protocol based on
national recommendations [2] made widely available to
medical and paramedical staff, with numerous in-house
information sessions over a number of years. Even so, it was
defective in one third of cases, although without impact in
terms of infection.
MRSA-positivity is rare and not systematically taken
into account, without apparent impact on infection risk. A
recent, statistically robust, study [25] reported no signif-
icant difference in MRSA SSI rates between non-screened
(0.99%) and screened (1.14%) cohorts (decontamination
and antibiotic prophylaxis adaptation). Kalmeijer et al.
studied the inefﬁcacy of nasal (mupirocin) decontamina-
tion in MRSA [26]. Two years previously, Kalmeijer et al.
showed that a high rate of nasal colonization was a major
SSI risk factor [27]. Perl et al. [28] reported that nasal
mupirocin prevented such infection. The debate is thus
not yet closed, and further study is required [29]. In our
institution, systematic screening ahead of TKA has been
discontinued.
The ‘‘ecological’’ environment of surgery in terms of
air and surfaces and their treatment is under control.
The change in habits involved in moving from surgical
hand-washing with antiseptic soap (2005) to surgical rub-
bing with a hydro-alcoholic solution (2006) would not
seem to have led to an increase in SSI rates (data
from targeted SSI surveillance in our orthopedic, vis-
ceral, urologic and neurologic surgery departments under
the SURVISO network piloted by the North Paris noso-
comial infection coordination center (CCLIN): overall SSI
rates were 2.72% in 2006, 0.90% in 2007 and 1.6% in
2008).
Conclusion
The initial hypothesis could not be conﬁrmed, because of
the limitations of epidemiological interpretation due to the
small number of infected patients and the problems raised
by postoperative surveillance. Defective implementation of
recommendations, notably regarding skin preparation, and
MRSA colonization did not seem to exacerbate risk. How-
ever, the weak points highlighted by the assessment are
perhaps relatively unimportant in as much as the time of
infection risk exposure (duration of surgery) is short, sur-
gical antibiotic prophylaxis is correctly implemented, skin
preparation conforms to generally accepted principles and
MRSA colonization seems not to play a major role in the
present ﬁndings.
[55
Our priority was to assess implementation of inherent
urgical infection risk prevention measures with respect
o forensic expertise in case of implant infection. Foren-
ic expertise analyzes the circumstances of infection onset,
everity, prevention measures undertaken (protocols, trace-
bility, assessments, epidemiological surveillance, proof of
n institutional infection risk prevention strategy) and the
uality of infection management. It is, however, sometimes
ifﬁcult to convince users that ‘‘zero risk’’ is but a pious
ope. This is all the harder to accept as the limits of pre-
ention would seem to have been reached and the notion of
npredictable treatment outcome is going to be with us for
long time to come.
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